X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17208) 17208
Book Chapter (60) 60
Newspaper Article (47) 47
Magazine Article (31) 31
Book / eBook (9) 9
Conference Proceeding (4) 4
Book Review (3) 3
Dissertation (3) 3
Streaming Video (3) 3
Newsletter (1) 1
Publication (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15193) 15193
male (11258) 11258
female (11125) 11125
ophthalmology (10934) 10934
middle aged (7992) 7992
visual acuity (7120) 7120
aged (6718) 6718
adult (6631) 6631
treatment outcome (4267) 4267
visual acuity - physiology (3950) 3950
follow-up studies (3333) 3333
retrospective studies (3311) 3311
aged, 80 and over (3046) 3046
tomography, optical coherence (2894) 2894
prospective studies (2814) 2814
visual acuity - drug effects (2687) 2687
surgery (2527) 2527
fluorescein angiography (2453) 2453
eye diseases (2205) 2205
macular degeneration (2163) 2163
intravitreal injections (2131) 2131
adolescent (2112) 2112
care and treatment (1842) 1842
genetic structures (1779) 1779
bevacizumab (1742) 1742
ranibizumab (1688) 1688
young adult (1671) 1671
vascular endothelial growth factor a - antagonists & inhibitors (1654) 1654
retina (1462) 1462
macular edema - drug therapy (1451) 1451
glaucoma (1433) 1433
patients (1429) 1429
eye (1389) 1389
child (1385) 1385
medicine & public health (1383) 1383
angiogenesis inhibitors - therapeutic use (1372) 1372
research (1359) 1359
diabetic retinopathy (1338) 1338
analysis (1280) 1280
risk factors (1276) 1276
time factors (1233) 1233
sense organs (1142) 1142
optical coherence tomography (1136) 1136
angiogenesis inhibitors - administration & dosage (1125) 1125
injections (1100) 1100
therapy (1054) 1054
intraocular pressure (1040) 1040
vascular endothelial growth factor (1035) 1035
studies (1019) 1019
edema (1017) 1017
acuity (1002) 1002
age (978) 978
choroidal neovascularization - drug therapy (977) 977
neurosciences (972) 972
animals (969) 969
abridged index medicus (934) 934
photodynamic therapy (924) 924
double-blind method (897) 897
vitreous body (895) 895
physiological aspects (866) 866
glucocorticoids - therapeutic use (862) 862
glucocorticoids - administration & dosage (861) 861
diabetes (848) 848
macular degeneration - drug therapy (829) 829
intraocular pressure - drug effects (805) 805
drug therapy (804) 804
endothelial growth-factor (801) 801
visual impairment (801) 801
macular edema - etiology (797) 797
antibodies, monoclonal, humanized (785) 785
drug therapy, combination (776) 776
fundus oculi (765) 765
diabetic retinopathy - drug therapy (758) 758
photochemotherapy (748) 748
photosensitizing agents - therapeutic use (745) 745
eyes (744) 744
health aspects (744) 744
clinical trials (741) 741
injection (733) 733
safety (732) 732
vision (732) 732
visual-acuity (729) 729
prevalence (728) 728
visual fields (727) 727
retina - pathology (703) 703
clinical neurology (699) 699
retinopathy (695) 695
medical imaging (694) 694
child, preschool (693) 693
uveitis (692) 692
vitrectomy (691) 691
management (688) 688
postoperative complications (682) 682
disease (675) 675
medicine (673) 673
age-related macular degeneration (648) 648
cataracts (648) 648
research article (644) 644
verteporfin (644) 644
visual perception (618) 618
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16601) 16601
German (284) 284
Russian (133) 133
French (121) 121
Polish (57) 57
Japanese (50) 50
Portuguese (39) 39
Chinese (38) 38
Spanish (33) 33
Romanian (31) 31
Czech (15) 15
Italian (7) 7
Danish (6) 6
Dutch (6) 6
Hungarian (5) 5
Hebrew (4) 4
Turkish (4) 4
Korean (3) 3
Icelandic (2) 2
Swedish (2) 2
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2017, Volume 317, Issue 20, pp. 2072 - 2087
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10085, pp. 2193 - 2203
... active neovascularisation with supplemental PRP. Repeated supplemental PRP is associated with permanent sequelae on visual function including final visual acuity... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | RANIBIZUMAB | LASER | Single-Blind Method | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Treatment Outcome | Diabetic Retinopathy - therapy | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Diabetic Retinopathy - physiopathology | Angiogenesis Inhibitors - administration & dosage | Visual Acuity - drug effects | Laser Coagulation - methods | Sensitivity and Specificity | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Aged | Laser Coagulation - adverse effects | Angiogenesis Inhibitors - adverse effects | Recombinant Fusion Proteins - administration & dosage | Diabetic retinopathy | Diabetics | Care and treatment | Medical research | Clinical trials | Medicine, Experimental | Ophthalmology | Retinopathy | Funding | Impairment | World Wide Web | Retina | Hemorrhage | Evidence-based medicine | Acceptability | Clinical outcomes | Visual perception | Acuity | Motivation | Lasers | Safety | Drug therapy | Vascular endothelial growth factor | Fluctuations | Effectiveness | Adjustment | Health | Diabetes mellitus | Visual acuity | Clarity | Patients | Adults | Diabetes | Cataracts | Edema | Diabetes mellitus (insulin dependent) | Randomization | Patient satisfaction | Variation
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2019, Volume 321, Issue 19, pp. 1880 - 1894
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, p. CD007419
.... These drugs have replaced laser photocoagulation as the standard of care for people with DMO... 
Endocrine & metabolic | Receptors, Vascular Endothelial Growth Factor | Vascular Endothelial Growth Factor A | Macular oedema | Laser Coagulation | Visual Acuity | Retinal disease | Angiogenesis Inhibitors | Recombinant Fusion Proteins | Bevacizumab | Randomized Controlled Trials as Topic | Diabetic eye disease | Aptamers, Nucleotide | Ranibizumab | Quality of Life | Macular Edema | Diabetes | Eyes & vision | Network Meta‐Analysis | Triamcinolone | Medicine General & Introductory Medical Sciences | Diabetic Retinopathy | Retinal disease (including age‐related macular degeneration) | CLINICAL-TRIAL | RANIBIZUMAB PLUS PROMPT | RANDOMIZED CONTROLLED-TRIAL | Receptors, Vascular Endothelial Growth Factor [therapeutic use] | DEFERRED LASER | MEDICINE, GENERAL & INTERNAL | PEGAPTANIB SODIUM | Bevacizumab [adverse effects; therapeutic use] | Laser Coagulation [methods] | Aptamers, Nucleotide [adverse effects; therapeutic use] | Network Meta-Analysis | QUALITY-OF-LIFE | Macular Edema [drug therapy; etiology; surgery] | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | Visual Acuity [drug effects; physiology] | COST-EFFECTIVENESS | Angiogenesis Inhibitors [adverse effects; therapeutic use] | LASER PHOTOCOAGULATION | Ranibizumab [adverse effects; therapeutic use] | Recombinant Fusion Proteins [adverse effects; therapeutic use] | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | Triamcinolone [adverse effects; therapeutic use] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2017, Volume 317, Issue 19, pp. 1993 - 2005
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 8, p. e0202549
Journal Article